Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $38.43 +9.52%
EPS Growth %: -35.0%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -35.0%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- South Korea's KOSPI Plunges 8%, Triggering Circuit Breaker
- JPMorgan Starts Central Depository Services India Ltd (CDSL:IN) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
